Literature DB >> 22647349

Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.

Nicholas P Tobin1, Katja L Lundgren, Catherine Conway, Lola Anagnostaki, Sean Costello, Göran Landberg.   

Abstract

The emergence of automated image analysis algorithms has aided the enumeration, quantification, and immunohistochemical analyses of tumor cells in both whole section and tissue microarray samples. To date, the focus of such algorithms in the breast cancer setting has been on traditional markers in the common invasive ductal carcinoma subtype. Here, we aimed to optimize and validate an automated analysis of the cell cycle regulator cyclin D1 in a large collection of invasive lobular carcinoma and relate its expression to clinicopathologic data. The image analysis algorithm was trained to optimally match manual scoring of cyclin D1 protein expression in a subset of invasive lobular carcinoma tissue microarray cores. The algorithm was capable of distinguishing cyclin D1-positive cells and illustrated high correlation with traditional manual scoring (κ=0.63). It was then applied to our entire cohort of 483 patients, with subsequent statistical comparisons to clinical data. We found no correlation between cyclin D1 expression and tumor size, grade, and lymph node status. However, overexpression of the protein was associated with reduced recurrence-free survival (P=.029), as was positive nodal status (P<.001) in patients with invasive lobular carcinoma. Finally, high cyclin D1 expression was associated with increased hazard ratio in multivariate analysis (hazard ratio, 1.75; 95% confidence interval, 1.05-2.89). In conclusion, we describe an image analysis algorithm capable of reliably analyzing cyclin D1 staining in invasive lobular carcinoma and have linked overexpression of the protein to increased recurrence risk. Our findings support the use of cyclin D1 as a clinically informative biomarker for invasive lobular breast cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647349     DOI: 10.1016/j.humpath.2012.02.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.

Authors:  Nicholas P Tobin; Linda S Lindström; Joseph W Carlson; Judith Bjöhle; Jonas Bergh; Kristian Wennmalm
Journal:  Mol Oncol       Date:  2014-02-28       Impact factor: 6.603

2.  Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.

Authors:  Max A K Rätze; Thijs Koorman; Thijmen Sijnesael; Blessing Bassey-Archibong; Robert van de Ven; Lotte Enserink; Daan Visser; Sridevi Jaksani; Ignacio Viciano; Elvira R M Bakker; François Richard; Andrew Tutt; Lynda O'Leary; Amanda Fitzpatrick; Pere Roca-Cusachs; Paul J van Diest; Christine Desmedt; Juliet M Daniel; Clare M Isacke; Patrick W B Derksen
Journal:  Oncogene       Date:  2022-04-18       Impact factor: 8.756

3.  High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.

Authors:  Cecilia Ahlin; Claudia Lundgren; Elin Embretsén-Varro; Karin Jirström; Carl Blomqvist; M -L Fjällskog
Journal:  Breast Cancer Res Treat       Date:  2017-05-20       Impact factor: 4.872

4.  PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.

Authors:  Vandna Shah; Salpie Nowinski; Dina Levi; Irek Shinomiya; Narda Kebaier Ep Chaabouni; Cheryl Gillett; Anita Grigoriadis; Trevor A Graham; Rebecca Roylance; Michael A Simpson; Sarah E Pinder; Elinor J Sawyer
Journal:  Breast Cancer Res       Date:  2017-01-17       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.